Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.4100
-0.0598 (-12.73%)
Oct 30, 2026, 12:47 PM EDT - Market open
Humacyte Market Cap
Humacyte has a market cap or net worth of $113.9 million as of October 30, 2026. It is the 23,306th most valuable company in the world and the 3,905th biggest in the United States. Its market cap has decreased by 64.01% in one year.
Market Cap
113.90M
Enterprise Value
100.87M
1-Year Change
-64.01%
Global Rank
Country Rank
#3,905 United States
Category
ChartMarket Cap Chart
Since December 1, 2020, Humacyte's market cap has decreased from $124.31M to $113.90M, a decrease of -8.37%. That is a compound annual growth rate of -1.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 113.90M | -38.56% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TuHURA Biosciences | 134.46M |
| Cue Biopharma | 133.08M |
| Innate Pharma | 132.80M |
| Spruce Biosciences | 131.20M |
| Armata Pharmaceuticals | 129.77M |
| Outlook Therapeutics | 128.98M |
| Nkarta | 121.76M |
| Foghorn Therapeutics | 121.74M |